<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; AMRI</title>
	<atom:link href="http://www.stockbloghub.com/tag/amri/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Sun, 20 May 2012 20:27:31 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(AMRI) &#8211; Albany Molecular Research &#8211; earnings of 24 cents per share, far ahead of analyst estimates of 10 cents</title>
		<link>http://www.stockbloghub.com/2008/10/09/amri-albany-molecular-research-earnings-of-24-cents-per-share-far-ahead-of-analyst-estimates-of-10-cents-4/880</link>
		<comments>http://www.stockbloghub.com/2008/10/09/amri-albany-molecular-research-earnings-of-24-cents-per-share-far-ahead-of-analyst-estimates-of-10-cents-4/880#comments</comments>
		<pubDate>Thu, 09 Oct 2008 13:00:51 +0000</pubDate>
		<dc:creator>Shawn</dc:creator>
				<category><![CDATA[Research Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AMRI]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/001880/2008/10/09/amri-albany-molecular-research-earnings-of-24-cents-per-share-far-ahead-of-analyst-estimates-of-10-cents-4</guid>
		<description><![CDATA[Albany Molecular Research, Inc. (AMRI) is weathering the current economic storm in commendable fashion. The company reported strong second-quarter results on Aug 6, forecasted a bullish full-year earnings projection and bears the favor of an accelerating share price.Company Description Albany Molecular Research provides contract services to pharmaceutical and biotechnology companies in the U.S. and internationally. The company was founded in 1991, has a market cap of $576 million and is headquartered in Albany, New York. Albany is one of the few company&#8217;s that has performed well in the choppy market over the last few weeks, with its share price actually hitting a new 52-week high. This strength is a product of Albany&#8217;s fundamental profile, on full display when the company reported excellent second-quarter results on Aug 6. Second-Quarter Results Revenue ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2008/10/09/amri-albany-molecular-research-earnings-of-24-cents-per-share-far-ahead-of-analyst-estimates-of-10-cents-4/880/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AMRI) &#8211; Albany Molecular Research &#8211; earnings of 24 cents per share, far ahead of analyst estimates of 10 cents</title>
		<link>http://www.stockbloghub.com/2008/10/07/amri-albany-molecular-research-earnings-of-24-cents-per-share-far-ahead-of-analyst-estimates-of-10-cents-3/820</link>
		<comments>http://www.stockbloghub.com/2008/10/07/amri-albany-molecular-research-earnings-of-24-cents-per-share-far-ahead-of-analyst-estimates-of-10-cents-3/820#comments</comments>
		<pubDate>Tue, 07 Oct 2008 13:21:41 +0000</pubDate>
		<dc:creator>Shawn</dc:creator>
				<category><![CDATA[Research Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AMRI]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/001820/2008/10/07/amri-albany-molecular-research-earnings-of-24-cents-per-share-far-ahead-of-analyst-estimates-of-10-cents-3</guid>
		<description><![CDATA[Albany Molecular Research, Inc. (AMRI) is weathering the current economic storm in commendable fashion. The company reported strong second-quarter results on Aug 6, forecasted a bullish full-year earnings projection and bears the favor of an accelerating share price.Company Description Albany Molecular Research provides contract services to pharmaceutical and biotechnology companies in the U.S. and internationally. The company was founded in 1991, has a market cap of $576 million and is headquartered in Albany, New York. Albany is one of the few company&#8217;s that has performed well in the choppy market over the last few weeks, with its share price actually hitting a new 52-week high. This strength is a product of Albany&#8217;s fundamental profile, on full display when the company reported excellent second-quarter results on Aug 6. Second-Quarter Results Revenue ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2008/10/07/amri-albany-molecular-research-earnings-of-24-cents-per-share-far-ahead-of-analyst-estimates-of-10-cents-3/820/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AMRI) &#8211; Albany Molecular Research &#8211; earnings of 24 cents per share, far ahead of analyst estimates of 10 cents</title>
		<link>http://www.stockbloghub.com/2008/10/02/amri-albany-molecular-research-earnings-of-24-cents-per-share-far-ahead-of-analyst-estimates-of-10-cents-2/775</link>
		<comments>http://www.stockbloghub.com/2008/10/02/amri-albany-molecular-research-earnings-of-24-cents-per-share-far-ahead-of-analyst-estimates-of-10-cents-2/775#comments</comments>
		<pubDate>Thu, 02 Oct 2008 16:20:11 +0000</pubDate>
		<dc:creator>Shawn</dc:creator>
				<category><![CDATA[Research Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AMRI]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/001775/2008/10/02/amri-albany-molecular-research-earnings-of-24-cents-per-share-far-ahead-of-analyst-estimates-of-10-cents-2</guid>
		<description><![CDATA[Albany Molecular Research, Inc. (AMRI) is weathering the current economic storm in commendable fashion. The company reported strong second-quarter results on Aug 6, forecasted a bullish full-year earnings projection and bears the favor of an accelerating share price.Company Description Albany Molecular Research provides contract services to pharmaceutical and biotechnology companies in the U.S. and internationally. The company was founded in 1991, has a market cap of $576 million and is headquartered in Albany, New York. Albany is one of the few company&#8217;s that has performed well in the choppy market over the last few weeks, with its share price actually hitting a new 52-week high. This strength is a product of Albany&#8217;s fundamental profile, on full display when the company reported excellent second-quarter results on Aug 6. Second-Quarter Results Revenue ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2008/10/02/amri-albany-molecular-research-earnings-of-24-cents-per-share-far-ahead-of-analyst-estimates-of-10-cents-2/775/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AMRI) &#8211; Albany Molecular Research &#8211; earnings of 24 cents per share, far ahead of analyst estimates of 10 cents</title>
		<link>http://www.stockbloghub.com/2008/10/01/amri-albany-molecular-research-earnings-of-24-cents-per-share-far-ahead-of-analyst-estimates-of-10-cents/742</link>
		<comments>http://www.stockbloghub.com/2008/10/01/amri-albany-molecular-research-earnings-of-24-cents-per-share-far-ahead-of-analyst-estimates-of-10-cents/742#comments</comments>
		<pubDate>Thu, 02 Oct 2008 03:20:10 +0000</pubDate>
		<dc:creator>Shawn</dc:creator>
				<category><![CDATA[Research Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AMRI]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/001742/2008/10/01/amri-albany-molecular-research-earnings-of-24-cents-per-share-far-ahead-of-analyst-estimates-of-10-cents</guid>
		<description><![CDATA[Albany Molecular Research, Inc. (AMRI) is weathering the current economic storm in commendable fashion. The company reported strong second-quarter results on Aug 6, forecasted a bullish full-year earnings projection and bears the favor of an accelerating share price.Company Description Albany Molecular Research provides contract services to pharmaceutical and biotechnology companies in the U.S. and internationally. The company was founded in 1991, has a market cap of $576 million and is headquartered in Albany, New York. Albany is one of the few company&#8217;s that has performed well in the choppy market over the last few weeks, with its share price actually hitting a new 52-week high. This strength is a product of Albany&#8217;s fundamental profile, on full display when the company reported excellent second-quarter results on Aug 6. Second-Quarter Results Revenue ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2008/10/01/amri-albany-molecular-research-earnings-of-24-cents-per-share-far-ahead-of-analyst-estimates-of-10-cents/742/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AMRI) &#8211; Albany Molecular Research &#8211; A 140% Earnings Surprise</title>
		<link>http://www.stockbloghub.com/2008/09/19/amri-albany-molecular-research-a-140-earnings-surprise-4/604</link>
		<comments>http://www.stockbloghub.com/2008/09/19/amri-albany-molecular-research-a-140-earnings-surprise-4/604#comments</comments>
		<pubDate>Fri, 19 Sep 2008 12:00:09 +0000</pubDate>
		<dc:creator>Shawn</dc:creator>
				<category><![CDATA[Research Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AMRI]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/001604/2008/09/19/amri-albany-molecular-research-a-140-earnings-surprise-4</guid>
		<description><![CDATA[Albany Molecular Research, (AMRI) has set a new 52-high coming off of a spectacular earnings announcement in August. The company has also initiated a Phase I study on a proprietary oncology drug and raised its full-year 2008 outlook.Company Description Albany Molecular Research, Inc. provides an extensive list of research and development services for pharmaceutical companies, such as drug development and chemistry research in addition to some small-scale production. The company was founded in Albany, New York, has approximately 1,200 employees, and carries a market cap of $575 million. A 140% Earnings Surprise On August 6th Albany Molecular reported second-quarter earnings of $5.7 million which. After adjusting for a restructuring charge, that translates to 24 cents per share. The consensus estimate was only 10 cents per share, yielding a 140% earnings ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2008/09/19/amri-albany-molecular-research-a-140-earnings-surprise-4/604/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AMRI) &#8211; Albany Molecular Research &#8211; A 140% Earnings Surprise</title>
		<link>http://www.stockbloghub.com/2008/09/17/amri-albany-molecular-research-a-140-earnings-surprise-3/570</link>
		<comments>http://www.stockbloghub.com/2008/09/17/amri-albany-molecular-research-a-140-earnings-surprise-3/570#comments</comments>
		<pubDate>Wed, 17 Sep 2008 12:20:15 +0000</pubDate>
		<dc:creator>Shawn</dc:creator>
				<category><![CDATA[Research Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AMRI]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/001570/2008/09/17/amri-albany-molecular-research-a-140-earnings-surprise-3</guid>
		<description><![CDATA[Albany Molecular Research, (AMRI) has set a new 52-high coming off of a spectacular earnings announcement in August. The company has also initiated a Phase I study on a proprietary oncology drug and raised its full-year 2008 outlook.Company Description Albany Molecular Research, Inc. provides an extensive list of research and development services for pharmaceutical companies, such as drug development and chemistry research in addition to some small-scale production. The company was founded in Albany, New York, has approximately 1,200 employees, and carries a market cap of $575 million. A 140% Earnings Surprise On August 6th Albany Molecular reported second-quarter earnings of $5.7 million which. After adjusting for a restructuring charge, that translates to 24 cents per share. The consensus estimate was only 10 cents per share, yielding a 140% earnings ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2008/09/17/amri-albany-molecular-research-a-140-earnings-surprise-3/570/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AMRI) &#8211; Albany Molecular Research &#8211; A 140% Earnings Surprise</title>
		<link>http://www.stockbloghub.com/2008/09/10/amri-albany-molecular-research-a-140-earnings-surprise-2/528</link>
		<comments>http://www.stockbloghub.com/2008/09/10/amri-albany-molecular-research-a-140-earnings-surprise-2/528#comments</comments>
		<pubDate>Wed, 10 Sep 2008 11:21:05 +0000</pubDate>
		<dc:creator>Shawn</dc:creator>
				<category><![CDATA[Research Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AMRI]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/001528/2008/09/10/amri-albany-molecular-research-a-140-earnings-surprise-2</guid>
		<description><![CDATA[Albany Molecular Research, (AMRI) has set a new 52-high coming off of a spectacular earnings announcement in August. The company has also initiated a Phase I study on a proprietary oncology drug and raised its full-year 2008 outlook.Company Description Albany Molecular Research, Inc. provides an extensive list of research and development services for pharmaceutical companies, such as drug development and chemistry research in addition to some small-scale production. The company was founded in Albany, New York, has approximately 1,200 employees, and carries a market cap of $575 million. A 140% Earnings Surprise On August 6th Albany Molecular reported second-quarter earnings of $5.7 million which. After adjusting for a restructuring charge, that translates to 24 cents per share. The consensus estimate was only 10 cents per share, yielding a 140% earnings ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2008/09/10/amri-albany-molecular-research-a-140-earnings-surprise-2/528/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AMRI) &#8211; Albany Molecular Research &#8211; A 140% Earnings Surprise</title>
		<link>http://www.stockbloghub.com/2008/09/05/amri-albany-molecular-research-a-140-earnings-surprise/464</link>
		<comments>http://www.stockbloghub.com/2008/09/05/amri-albany-molecular-research-a-140-earnings-surprise/464#comments</comments>
		<pubDate>Sat, 06 Sep 2008 01:40:11 +0000</pubDate>
		<dc:creator>Shawn</dc:creator>
				<category><![CDATA[Research Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AMRI]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/001464/2008/09/05/amri-albany-molecular-research-a-140-earnings-surprise</guid>
		<description><![CDATA[Albany Molecular Research, (AMRI) has set a new 52-high coming off of a spectacular earnings announcement in August. The company has also initiated a Phase I study on a proprietary oncology drug and raised its full-year 2008 outlook.Company Description Albany Molecular Research, Inc. provides an extensive list of research and development services for pharmaceutical companies, such as drug development and chemistry research in addition to some small-scale production. The company was founded in Albany, New York, has approximately 1,200 employees, and carries a market cap of $575 million. A 140% Earnings Surprise On August 6th Albany Molecular reported second-quarter earnings of $5.7 million which. After adjusting for a restructuring charge, that translates to 24 cents per share. The consensus estimate was only 10 cents per share, yielding a 140% earnings ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2008/09/05/amri-albany-molecular-research-a-140-earnings-surprise/464/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

